CRSP is a speculative buy for aggressive investors, driven by the commercial launch and multibillion-dollar potential of ...

Shares of CRISPR Therapeutics CRSP have rallied 41.4% in the past three months, driven by encouraging data from a study of ...

There were more than 48,000 organ transplants in the U.S. in 2024, a 3.3% increase from 2023, according to Organ Procurement ...

CRISPR Therapeutics has rallied on Casgevy progress, but overvaluation, early-stage pipeline, and lack of profits raise ...

The company's path to creating life-changing returns hinges on its ability to deliver consistent clinical and regulatory wins ...

For years, researchers have been trying to figure out how to treat inherited blood disorders like sickle cell disease without ...

A new generation of CRISPR technology developed at UNSW Sydney offers a safer path to treating genetic diseases like sickle ...

Discover the transformative shifts in the Plant Breeding and CRISPR Plants market with the latest 360 Quadrants analysis. This comprehensive industry evaluation categorizes over 190 companies, ...

Cleaved Diagnostics, a biotechnology startup spinning out of Tulane University, has been awarded a Phase I Small Business ...

CRISPR uncovers gene that supercharges vitamin D—and stops tumors in their tracks Scientists hail key gene with promising ‘new avenues’ for precision medicine through CRISPR/Cas9.

CRISPR is a technology that can be used to edit genes and, as such, will likely change the world. The essence of CRISPR is simple: it’s a way of finding a specific bit of DNA inside a cell. After that ...

Comprehensive account reveals how Berkeley expanded from academic stronghold to entrepreneurship leader while advancing its public mission BERKELEY, CA / ACCESS Newswire / August 19, 2025 / UC Berkele ...